-- China commercial launch in multiple provinces and municipalities expected to begin in Q1 2023, and Clover anticipates a significant and sustained long-term annual booster market for its premium, ...
Read Coronavirus vaccine latest news on The Economic Times. When will coronavirus vaccine be available in India? Coronavirus ...
Read Covid-19 Vaccine latest news on The Economic Times. When will Covid-19 Vaccine be available in India? Covid-19 Vaccine ...
Moderna (NasdaqGS:MRNA) has expanded its collaboration with CEPI to accelerate development of an mRNA vaccine targeting ...
TAIPEI -The Chinese sales agent for Germany's BioNTech SE said on Sunday it had signed a deal to provide 10 million COVID-19 ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE - A nurse practitioner holds a COVID-19 vaccine card at a New York Health and Hospitals vaccine clinic in the Brooklyn ...
Panacea Biotec share price hits 20 per cent upper circuit at Rs 202.80 apiece on BSE after the biotechnology company announced a collaboration with US-based Refana for coronavirus vaccine on Tuesday.
The Palladium-Item on MSN
Here's what to know about the FDA's COVID-19 vaccine changes
The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results